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1995; Biassoni et al., 1996); they are designated hereThe presence and expression of killer inhibitory recep-
as ªnoninhibitory KIR.ºtor (KIR) and CD94:NKG2 genes from 68 donors were
Every person can be expected to express HLA classanalyzed using molecular typing techniques. The
I molecules that engage the CD94:NKG2-A receptor,genes encoding CD94:NKG2 receptors were present
whereas the number of KIR ligands depends on a per-in each person, but KIR gene possession varied. Most
son's HLA type. Three kinds of inhibitory KIR have well-individuals expressed inhibitory KIR for the three well-
defined HLA ligands, and an individual can have one,defined HLA-B and -C ligands, but noninhibitory KIR
two, or three of these: inhibitory KIR with two IgSF do-genes were more variable. Twenty different KIR phe-
mains recognize subsets of HLA-C allotypes determinednotypes were defined. Two groups of KIR haplotypes
by alternative amino acid sequence motifs at positionswere distinguished and occurred at relatively even fre-
77 and 80 of the a1 helix (Colonna et al., 1993). A KIRquency. Group A KIR haplotypes consist of six genes:
with three IgSF domains recognizes thesubset of HLA-Bthe main inhibitory KIR, one noninhibitory KIR, and a
allotypes that share the Bw4 sequence motif at positionsstructurally divergent KIR. Allelic polymorphism within
77±83 of the a1 helix (Litwin et al., 1994; Gumperz et al.,five KIR genes was detected. Group B comprises more
1995).noninhibitory KIR genes and contains at least one ad-
The genes for KIR, CD94:NKG2, and HLA are on differ-ditional gene not represented in group A. The KIR locus
ent chromosomes (Yabe et al., 1993; Baker et al., 1995;therefore appears to be polygenic and polymorphic
Chang et al., 1995; Colonna and Samaridis, 1995; Wagt-within the human population.
mann et al., 1995), so that ligands and receptors segre-
gate independently in human pedigrees. As a conse-Introduction
quence, a substantial proportion of the population has
genes for KIR for which they have no HLA class I ligandNatural killer (NK) cell function is regulated by the inter-
(Gumperz et al., 1996). In the present investigation, weaction of major histocompatibility (MHC) class I mole-
used novel molecular typing techniques for KIR andcules with inhibitory cell surface receptors (Yokoyama,
NKG2 genes to analyze a sample population, revealing1993; Lanier and Phillips, 1996). This mechanism is be-
an extensive polymorphism in KIR genotypes.lieved to protect healthy cells from lysis by autologous
NK cells, while rendering cells for which class I expres-
sion is compromised by infection or transformation sus- Results
ceptible to NK cell-mediated lysis (Ljunggren and KaÈ rre,
1990). Unlike cytotoxic CD81 T cells, which require rec- A System for Typing Patterns of KIR
ognition of a specific MHC class I allotype to lyse a and NKG2 mRNA Expression
target, NK cells are prevented from lysing a target by To assess variation in the repertoires of KIR and NKG2
recognition of MHC class I (KaÈ rre et al., 1986; Storkus HLA class I receptors expressed by individual humans,
typing assays based on the reverse transcription poly-
merase chain reaction (RT-PCR) were developed. The§To whom correspondence should be addressed (e-mail: peropa@
leland.stanford.edu). design of the KIR typing system was guided by the
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Table 1. PCR Primers
PCR Group Templatea Sense Primer (59-39) Antisense Primer (59-39) Locationb Lengthc
KIR2DL1 RNA GCA GCA CCA TGT CGC TCT GTC ACT GGG AGC TGA CAC 28±348 356
KIR2DL1 DNA ACT CAC TCC CCC TAT CAG G AGG GCC CAG AGG AAA GTC A 315±567 z1750
KIR2DL2 RNA CCA CTG CTT GTT TCT GTC AT CAG CAT TTG GAA GTT CCG C 645±1015 370
KIR2DL2 DNA CCA TGA TGG GGT CTC CAA A GCC CTG CAG AGA ACC TAC A 228±523 z1800
KIR2DL3 RNA CCA CTG AAC CAA GCT CCG CAG GAG ACA ACT TTG GAT CA 692±1044 352
KIR2DL3 DNA CCT TCA TCG CTG GTG CTG CAG GAG ACA ACT TTG GAT CA 792±1043 798
KIR2DL4 RNA CTG TCC CTG AGC TCT ACA A CAC TGA GTA CCT AAT CAC AG 206±747 541
KIR3DL1 RNA ACA TCG TGG TCA CAG GTC C TGC GTA TGT CAC CTC CTC 641±1197 556
KIR3DL1 DNA CCA TCG GTC CCA TGA TGC T AGA GAG AAG GTT TCT CAT ATG 542±679 z1600
KIR3DL2 RNA;DNA CGG TCC CTT GAT GCC TGT GAC CAC ACG CAG GGC AG 546±914 368; z1900
KIR2DS1 RNA;DNA TCT CCA TCA GTC GCA TGA A/G AGG GCC CAG AGG AAA GTT 254±567 313; z1800
KIR2DS2 RNA;DNA TGC ACA GAG AGG GGA AGT A CAC GCT CTC TCC TGC CAA 179±435 256; z1750
KIR2DS3 RNA;DNA TCA CTC CCC CTA TCA GTT T GCA TCT GTA GGT TCC TCC T 315±594 279; z1800
KIR2DS4 RNA;DNA CTG GCC CTC CCA GGT CA GGA ATG TTC CGT TGA TGC 94±544 450; z2000
KIR2DS5 RNA;DNA AGA GAG GGG ACG TTT AAC C GCC GAA GCA TCT GTA GGC 184±600 416; z1950
KIR3DS1 RNA GGC ACC CAG CAA CCC CA AAG GGC ACG CAT CAT GGA 321±567 246; z1750
KIR3DS1 DNA GGC AGA ATA TTC CAG GAG G AGG GGT CCT TAG AGA TCC A 217±493 z1800
CD94 RNA GCA GTG TTT AAG ACC ACT CT CTG TTG CTT ACA GAT ATA ACG 4±531 527
NKG2-A RNA CCA GAG AAG CTC ATT GTT GG CCA ATC CAT GAG GAT GGT G 202±527 325
NKG2-A DNA AGG AGT AAT CTA CTC AGA CC AGG GAA TAA CAA CTA TCG TTA C 12±283 661
NKG2-C RNA GGA AAT ATT CCA AGT AGA ATT AAA T CTG ATG CAC TGT AAA CGC AAA T 108±727 619
NKG2-C DNA TTT CTG GCC AGC ATT TTA CCT CTG ATG CAC TGT AAA CGC AAA T 477±727 z1100
NKG2-D RNA CTG GGA GAT GAG TGA ATT TCA TA GAC TTC ACC AGT TTA AGT AAA TC 35±451 416
NKG2-E RNA CTG TGC TTC AAA GAA CTC TTC T CTG GTC TGA TAT AAG TCC ACG T 432±657 225
a Primer pairs were used for RNA-based typing (RNA), genomic typing (DNA), or both (RNA; DNA).
b Nucleotide positions of amplified fragments were calculated from the start codon according to the sequences previously reported (Houchins
et al., 1991; Adamkiewicz et al., 1994; Biassoni et al., 1995; Colonna and Samaridis, 1995; D'Andrea et al., 1995; Wagtmann et al., 1995;
DoÈ hring et al., 1996a; and Selvakumar et al., 1996).
c In cases where primer pairs were used for RNA- and DNA-based typing, the length (in base pairs) of the RT-PCR fragment is given first.
topology of a tree of KIR sequences. The 12 groups of typing system was applied to RNA samples from donors
PP and NV, the types obtained correlated precisely withKIR chosen as the types to be defined in the assay
represent the smallest clades of the tree (Valiante et those determined by cDNA cloning (data not shown).
Similar analysis of individual NK cell clones obtainedal., 1997a). Oligonucleotide primer pairs (Table 1) were
designed to match polymorphic positions unique to from PP and NV showed that the KIR and NKG2 type
obtained with the PCR assay corresponded to that de-each KIR group, as determined from an alignment of 36
different KIR sequences. The resulting assay accounts termined using a panel of KIR- and NKG2-specific anti-
bodies and flow cytometry (Figure 1).for all reported KIR sequences (except certain alterna-
tive splice variants) and permits comparison of the five
groups of inhibitory KIR (KIR2DL1±3 and KIR3DL1±2), The Combination of KIR Genes Expressed Is Highly
Polymorphic in the Human Populationthe six groups of noninhibitory KIR (KIR2DS1±5 and
KIR3DS1), and the unusual KIR2DL4, for which a func- Using the RT-PCR±based typing system, peripheral
blood mononuclear cells (PBMC) from 52 blood donorstion has yet to be assigned (Table 2). Each KIR group
comprises one to six members, which differ by 1±9 nu- were compared for their expression of KIR and NKG2.
Considerable variability in KIR expression was ob-cleotide substitutions and may represent alleles. By con-
trast, members of different groups differ by 20 nucleo- served. Within this panel, which consisted mostly of
caucasoid donors, 18 different phenotypes were de-tides or more. Expression of the four NKG2 genes was
monitored with specific amplifications covering the in- tected (Table 3). The most common phenotype was
present in 33% of the donors and was composed ofhibitory NKG2-A gene (NKG2-B is a mRNA splice variant
of NKG2-A) (Plougastel et al., 1996); the noninhibitory four major inhibitory KIR (KIR2DL1, KIR2DL3, and
KIR3DL1±2), the noninhibitory KIR2DS4, and the divergentNKG2-C; and the NKG2-D and NKG2-E genes, of un-
known function. KIR2DL4. The other KIR phenotypes were less common;
they were found in 2%±8% of the panel. Whereas theThe validity of the PCR typing system was demon-
strated in several ways. First, it was demonstrated by common phenotype consisted of KIR from six different
amplification groups, the less common phenotypesdirect sequencing of the PCR products obtained from
two ªcontrolº individuals (donors PP and NV) for whom could include KIR from as many as ten of the amplifica-
tion groups (Figure 2A).the expressed KIR and NKG2 genes had been deter-
mined by cloning and sequencing of cDNA (Valiante et Three KIR groups were represented in all the individu-
als typed: KIR2DL1 and KIR3DL2 of the inhibitory typeal., 1997b [this issue of Immunity]). Second, its validity
was demonstrated by application of the typing system to and KIR2DL4. The majority of individuals expressed four
different inhibitory KIR (Figure 2B). KIR with the twoa panel of seven transfected cell lines, each expressing
single KIR or the lectin-like NKG2-A. When the PCR different HLA-C inhibitory specificities were present in
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Table 2. PCR-Defined Groups of KIR Sequences
Groupa Structure Specificityb cDNA Namec Amino Acid Substitutionsd
KIR2DL1 2Ig, inhibitory C2 P58cl47-11 5V, 132R, 230L
NKAT1 5V, 132P, 230P
P58cl42 5F, 132P, 230P
KIR2DL2 2Ig, inhibitory C1 NKAT6 385R, 386Q
p58cl43 385S, 386E
KIR2DL3 2Ig, inhibitory C1 NKAT2/p58cl6 9V, 127L, 151Q, 166H, 324P, 338H 399A, 413R
NKAT2A 9V, 127L, 151Q, 166H, 324L, 338H, 399A, 413H
NKAT2B 9V, 127L, 151Q, 166H, 324P, 338H, 399T, 413R
KIR-023GB 9A, 127R, 151E, 166R, 324P, 338I, 399A, 413R
KIR2DL4 2Ig KIR-103AS 138T, 209A, 271D
KIR-103LP 138A, 209P, 271N
KIR3DL1 3Ig, inhibitory Bw4 NKAT3/AMB11/cl11 2S, 13L, 23M, 68I, 75I, 259G
NKB1/cl2 2L, 13F, 23V, 68V, 75L, 259R
KIR3DL2 3Ig, inhibitory A? cl5/AMC5 40P, 113L, 158D, 166R, 228A, 252I
NKAT4 40P, 113L, 158E, 166R, 228A, 252I
NKAT4A/cl1-1 40P, 113V, 158E, 166R, 228A, 252I
NKAT4B 40P, 113V, 158E, 166H, 228A, 252I
17-1c 40A, 113V, 158E, 166H, 228P, 252T
8-11c 40A, 113V, 158E, 166H, 228A, 252I
KIR2DS1 2Ig, noninhibitory C2 EB6act1 4T, 186R
EB6act2 4M, 186K
KIR2DS2 2Ig, noninhibitory C1 NKAT5/p58cl49 20G
GL183act1 20W
KIR2DS3 2Ig, noninhibitory NKAT7
KIR2DS4 2Ig, noninhibitory NKAT8/cl39
KIR2DS5 2Ig, noninhibitory NKAT9
KIR3DS1 3Ig, noninhibitory NKAT10 166R
123FM 166H
a KIR genes were designated according to nomenclature agreed upon by E. Long (National Institutes of Health, Bethesda, MD) L. Lanier
(DNAX, Palo Alto, CA), and M. Colonna (Basel Institute, Basel, Switzerland). KIR2D and KIR3D refer to receptors with two or three IgSF
domains, respectively. L stands for receptors having long and S for those having short cytoplasmic tails, consistent with the presence or
absence of ITIM motifs, respectively. Each KIR subfamily is designated by an individual number, for example KIR2DS1. In tables and figures
the receptor subfamilies are sometimes abbreviated (e.g., 2DS1).
b The C1 and C2 groups of HLA-C alleles are distinguished by the dimorphic positions Ser 77±Asn 80 (C1) and Asn 77±Lys 80 (C2) (Colonna
et al., 1993).
c Sequences with identical coding regions are listed together and separated by a slash. No alternative splicing forms are listed.
d Amino acid substitutions between members of each group and their positions as calculated from the start codon are shown.
all individuals; KIR2DL1 represented one specificity and random association, whereas one combination (KIR2DS3/
2DS4) was found at less than the expected value (Tableeither KIR2DL2 or KIR2DL3 represented the other (Table
3). By contrast, the HLA-B±specific inhibitory receptor, 4). The former phenomenon could be due to linkage
disequilibrium, indicating that these combinations ofKIR3DL1, was not expressed by four members of the
panel. These appear to be true negative results, since KIR represent haplotypes. One putative haplotype com-
prises the inhibitory KIR2DL2 and the noninhibitoryantibodies specific for KIR3DL1 failed to bind these indi-
viduals' NK cells and since amplification with alternative KIR2DS2 and KIR2DS3. Linkage was also detected be-
tween the two noninhibitory KIR2DS1 and KIR3DS1,sets of primers specific for KIR3DL1 gave similarly nega-
tive results (data not shown). which are expressed together in 19 of the 21 samples
expressing either KIR2DS1 or KIR3DS1. Segregation ofThe majority of the polymorphism in the expressed
KIR phenotypes is due to the noninhibitory receptors. these two linkage groups was observed in a family,
where donor NV inherited KIR2DL2, KIR2DS2, andEvery individual expresses between one and five nonin-
hibitory KIR (Figure 2B). None of these receptor groups KIR2DS3 from his mother and KIR2DS1 and KIR3DS1
from his father. KIR2DL2 was present in all samplesis shared by all individuals, the most common, KIR2DS4,
being represented in 80% of the panel (Figure 3). With negative for KIR2DL3, a finding suggesting that these
two functionally similar inhibitory KIR segregate on dif-one exception, the other noninhibitory KIR were repre-
sented in 27% or more of the panel. KIR2DS5 was not ferent haplotypes. The four samples, which were nega-
tive for the inhibitory KIR3DL1, were positive for therepresented in the donor panel, although it could be
amplified from the original cDNA clone, suggesting that noninhibitory KIR3DS1, which is the most similar KIR.
Again, this finding argues that these two receptors seg-this KIR is relatively uncommon.
The frequency with which certain combinations of KIR regate independently and that they are related to each
other as alleles.are expressed by individuals exceeded that predicted by
Immunity
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Figure 1. Detectionof KIR and NKG2-A Tran-
scripts in NK Clones by RT-PCR Correlates
with Surface Expression
Three representative NK clones from donor
PP were analyzed by RT-PCR for expres-
sion of KIR2DL1, KIR2DL3, KIR3DL1±2, and
KIR2DS4 as well as the lectin-like receptors
CD94 and NKG2-A (left). Detection of KIR or
NKG2-A transcripts by RT-PCR correlated
with receptor surface expression as deter-
mined by flow cytometry analysis using MAbs
against KIR2DL1 (HP-3E4), KIR2DL3 (DX27),
KIR3DL1 (DX9), and KIR3DL2 (DX31) as well
as an CD94:NKG2-A±specific antiserum (right).
Donor PP does not express the noninhibitory
KIR2DS1 and KIR2DS2, which are also recog-
nized by MAbs HP-3E4 and DX27, respec-
tively (Lanier et al., 1997). Second-step anti-
bodies alone served as negative controls.
Variability in the expression of the NKG2 receptor fam- limited than that for KIR, it is similarly focused on a
noninhibitory receptor, NKG2-C.ily was also observed. The inhibitory receptor NKG2-A
was found to be expressed by all individuals, whereas in
six samples no expression of the noninhibitory NKG2-C Distinct Patterns of KIR Expression Are Due
to Differences in KIR Genesreceptor was found (data not shown). The presence or
absence of NKG2-C expression was not correlated with The variation of KIR gene expression in thehuman popu-
lation raised the question of whether it is due primarilythe expression of particular KIR haplotypes. The NKG2-D
and NKG2-E genes, for which functions are unknown, topolymorphism of the genes or todifferential regulation
of gene expression. To address this issue, we developedare expressed by all the individuals we analyzed. Al-
though the variation in NKG2 gene expression is more a method for PCR typing of KIR and NKG2 genes using
Table 3. KIR Expression Patterns in the Population Survey
KIR
Phenotype 2DL1 2DL3 3DL1 3DL2 2DL2 2DS1 2DS2 2DS3 2DS4 3DS1 2DL4 Numbera Frequency (%)
1 (PP) 1 1 1 1 2 2 2 2 1 2 1 17 33
2 1 1 1 1 2 2 1 2 1 2 1 4 7.70
3 1 1 1 1 1 2 1 1 1 2 1 4 7.70
4 1 1 1 1 2 1 2 2 1 1 1 4 7.70
5 (NV) 1 2 1 1 1 1 1 1 1 1 1 3 5.80
6 1 1 1 1 1 1 1 1 2 1 1 3 5.80
7 1 1 1 1 1 2 1 2 1 2 1 3 5.80
8 1 1 1 1 2 1 1 2 1 1 1 2 3.80
9 1 1 1 1 1 1 1 2 1 1 1 2 3.80
10 1 1 1 1 1 2 1 1 2 2 1 2 3.80
11 1 1 1 1 1 2 2 2 1 2 1 1 1.90
12 1 2 2 1 1 1 1 1 2 1 1 1 1.90
13 1 1 1 1 1 2 1 2 1 1 1 1 1.90
14 1 1 2 1 2 1 2 2 2 1 1 1 1.90
15 1 1 2 1 1 1 1 1 2 1 1 1 1.90
16 1 1 2 1 2 1 2 2 1 1 1 1 1.90
17 1 1 1 1 2 1 2 2 2 1 1 1 1.90
18 1 1 1 1 2 1 1 2 2 2 1 1 1.90
a A total of 52 individuals were analyzed.
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Table 4. Association of KIR in a Survey of 52 Individuals
KIR Combination Observeda Expectedb Factorc
2DL2/2DS2/2DS3 26.9 5.64 4.77
2DL2/2DS3 26.9 10.9 2.47
2DS1/3DS1 36.5 14.9 2.44
2DS2/2DS3 26.9 13.9 1.94
2DL2/2DS2 38.5 20.9 1.84
2DS1/2DS3 15.4 10.4 1.48
2DS3/3DS1 15.4 10.4 1.48
2DL2/3DS1 21.2 15.6 1.36
2DS1/2DS2 25 19.9 1.26
2DS2/3DS1 25 19.9 1.26
2DL2/2DS1 19.2 15.6 1.23
2DL2/2DS4 32.6 26.9 1.21
2DS2/2DS4 36.5 41.9 0.87
2DS4/3DS1 25 30.9 0.81
2DS1/2DS4 23.1 31.1 0.74
2DS3/2DS4 13.5 21.7 0.62
a Observed frequencies of KIR combinations in a survey of 52 sam-
ples. KIR combinations shown underlined are associated more fre-
quently (P , 0.0001) than expected by random association, as deter-
mined by a test of statistical independence (G test). The results for
KIR2DL1, KIR2DL3±4, and KIR3DL1±2 are not shown because they
are expressed at frequencies greater than 0.9.
b Expected frequencies for KIR combinations are the product of
each receptor's individual frequency.
c The fold increase of the observed frequencies over the expected
frequencies.Figure 2. Variation in the Number and Type of KIR Genes Expressed
by Different Individuals
KIR expression by PBMC was analyzed by KIR-specific RT-PCR.
(A) The total number of KIR expressed by individuals is plotted as KIR types were obtained in the two assays, a result that
a frequency distribution within the panel (n 5 52). extended to all of ten other individuals analyzed (Figure
(B) The number of inhibitory (open bars) and noninhibitory (filled
4). In no instance did an individual possess a KIR genebars) KIR is compared. The divergent KIR2DL4 of unknown function
that was not found to be expressed by some cells withinthat is expressed by all individuals is included in the analysis shown
the population of PBMC. This correlation demonstratesin (A) but not that in (B).
that differences in the KIR expressed by individuals
within the human population result from structural poly-
morphisms of the KIR gene family rather than from poly-genomic DNA as the template. We modified the primers
used in the RT-PCR assay in order to limit the length of morphisms in the regulation of their expression.
DNA typing of KIR genes was next performed for 18the amplification products to no more than 2 kb (Table
1). The DNA-based typing system was applied to sam- individuals of different ethnicity (Table 5). Within this
panel the commonest genotype corresponded to theples of genomic DNA obtained from PBMC and the re-
sults compared to those obtained by RT-PCR typing of common phenotype seen at the RNA level in thepanel of
52 mostly caucasoid individuals. This genotype, whichthe same preparations of PBMC. For donors PP and
NV, for whom the expressed KIR are known, identical carries a single noninhibitory KIR gene (KIR2DS4), was
Figure 3. The Frequencies with Which Indi-
vidual KIR Groups Are Expressed
Shown are the percentages of individuals
within the panel (n 5 52) who express each
inhibitory KIR group (open bars), noninhibi-
tory KIR group (solid bars), and the divergent
KIR2DL4 group (hatched bars).
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more diverse panel of donors were also analyzed by
Southern blotting. Those individuals with the most com-
mon KIR genotype showed the same banding pattern,
as presented inFigure 5 for digestion with HindIII. Similar
bands were also seen for individuals having less com-
mon KIR genotypes, but they were distinguished by
an additional, large and prominent HindIII fragment of
about 24 kb.
In contrast to the KIR gene family, all individuals ana-
lyzed possessed genes encoding NKG2-A, NKG2-C,
NKG2-D, and NKG2-E. Southern blotting analysis showed
no variation in the banding patterns for the NKG2 and
CD94 genes (data not shown), although for some of the
donors we were unable to detect NKG2-C transcripts.
In combination, the results obtained from KIR geno-
typing and Southern blotting indicate that the KIR haplo-
types segregating in the human population can be di-
vided into two broad groups. We will refer to these as
the group A and the group B haplotypes. Distinguishing
the two groups of haplotypes is the 24 kb HindIII band
seen on Southern blots, which is present in group B
haplotypesand absent from group A haplotypes.Whereas
the heterogeneity within the group B haplotypes is ap-
parent from KIR genotyping, by that method of analysis
the group A haplotypes appear homogeneous. Individu-
als who express two group A haplotypes are those hav-
ingthe common KIR genotype and phenotype. However,
an underlying heterogeneity in the group A haplotypes
is revealed by the sequence analysis of KIR from donor
PP, who possesses two group A haplotypes. Determina-
tion of complete KIR sequences shows that donor PP
expresses two different but closely related alleles for
five of the six different types of KIR associated with the
group A haplotypes.
Based on Southern blotting and KIR typing results,
we can confidently characterize 27 individuals of the
panel of 68 donors as homozygous for group A haplo-
types and 17 individuals as homozygous for group B
haplotypes. Each of the remaining 24 donors could be
either heterozygous for group A and B haplotypes or
homozygous for group B haplotypes. At one end of the
range of possibilities, 40% of the haplotypes would be
of group A and 60% of group B, while at the other end
57% of the haplotypes would be of group A and 43%
of group B. Throughout this range, the frequencies of
group A and B haplotypes both are between 0.4 and
0.6 and therefore of comparable magnitude.
Figure 4. Variability of KIR Usage Is Determined at the Genomic
Level Discussion
The presence of transcripts and genes corresponding to the indi-
cated NK receptor groups was determined by RT-PCR and genomic Human NK cells use both lectin-like and immunoglobu-
PCR, respectively. A b-actin±specific primer pair was included in
lin-like molecules as their inhibitory receptors for HLAeach RT-PCR amplification as an internal positive control and its
class I molecules (reviewed by Lanier et al., 1997; Vali-product of 734 bp indicated. The results from 5 representative do-
ante et al., 1997b). In addition to their distinctive struc-nors of a total of 12 analyzed are shown.
tures, these two kinds of receptors have complementary
specificities: the lectin-like receptor CD94:NKG2-A en-
found in 11 of the 18 panel members, including the PP gages most HLA-A, -B, and -C allotypes, whereas the
control. The remaining 7 members of the panel, including immunoglobulin-like KIR are specific for subsets of
the NV control, had a variety of genotypes, generally HLA-B or -C allotypes. Because their HLA class I ligands
characterized by an increased number of genes for non- are polymorphic, we investigated whether the receptors
inhibitory receptors. Among these were two additional also exhibit diversity within the human populations.
genotypes that had not been found in the mostly cauca- From PCR-based molecular typing and Southern blot-
ting, no evidence for variation in the number of CD94soid panel of 52 donors. The KIR genes of the ethnically
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Table 5. KIR Genotypes of Ethnically Diverse Panel
Donor Ethnicity Inhibitory KIR Noninhibitory KIR Haplotype Groupa
C1 (PP) Caucasoid 2DL1, 2DL3, 3DL1-2 2DS4 A
B1 Black American 2DL1, 2DL3, 3DL1-2 2DS4 A
E1 East Indian 2DL1, 2DL3, 3DL1-2 2DS4 A
F2 Filipino 2DL1, 2DL3, 3DL1-2 2DS4 A
C1 Chinese 2DL1, 2DL3, 3DL1-2 2DS4 A
K1 Korean 2DL1, 2DL3, 3DL1-2 2DS4 A
K2 Korean 2DL1, 2DL3, 3DL1-2 2DS4 A
J3 Japanese 2DL1, 2DL3, 3DL1-2 2DS4 A
J4 Japanese 2DL1, 2DL3, 3DL1-2 2DS4 A
H1 Hispanic 2DL1, 2DL3, 3DL1-2 2DS4 A
H2 Hispanic 2DL1, 2DL3, 3DL1-2 2DS4 A
C2 (NV) Caucasoid 2DL1-2, 3DL1-2 2DS1-4, 3DS1 B
B2 Black American 2DL1, 2DL3, 3DL1-2 2DS1, 2DS4, 3DS1 B
E2 East Indian 2DL1, 2DL3, 3DL1-2 2DS1, 2DS4, 3DS1 B
F3 Filipino 2DL1-3, 3DL1-2 2DS2 B
C2 Chinese 2DL1, 2DL3, 3DL1-2 2DS1, 2DS3, 3DS1 B
A1 American Indian 2DL1, 2DL3, 3DL1-2 2DS1, 2DS4, 3DS1 B
B3 Black American 2DL1-3, 3DL1-2 2DS1-3, 3DS1 B
a Donors assigned haplotype group B may also have a group A haplotype.
and NKG2 genes was obtained, whereas striking differ- of the inhibitory KIR, there is substantial variation in the
number and type of noninhibitory KIR.ences in the KIR genes were apparent. All of the KIR
genes possessed by an individual are expressed, A minimumof 14different KIR haplotypes can account
for the 20 KIR phenotypes found for the 68 individualsthough not necessarily on every NK cell. At the level of
the NK cell population as a whole, the KIR phenotype analyzed in thisstudy. Given the small sizeof the popula-
tion analyzed and its limited coverage of the world'scorrelated precisely with the KIR genotype.
The molecular typing we used was designed to distin- populations, these haplotypes probably represent a mi-
nority of the total number. The KIR haplotypes divideguish the major kinds of KIR that have been defined by
the cloning and sequencing of cDNA. Three kinds of KIR into two groups distinguished by the absence (group A
haplotypes) or presence (group B haplotypes) of a 24 kbwere expressed by all 68 blood donors we examined:
the inhibitory KIR2DL1, which is specific for group 2 HindIII fragment on Southern blotting. The two kinds of
haplotype have relatively even frequencies, and for theHLA-C allotypes; KIR3DL2, an inhibitory receptor of less
clear specificity, which includes certain HLA-A allotypes panel of individuals we analyzed there appears to be an
excess of homozygotes over that expected by random(DoÈ hring et al., 1996b; Pende et al., 1996); and the diver-
gent KIR2DL4, of unknown specificity. Most donors association. Although this feature could well be due to
the artificial nature of our sample population, it raiseshave genes encoding inhibitory KIR specific for the three
major ligands: group 1 HLA-C, group 2 HLA-C, and Bw4 the possibility of a role for selection.
In PCR genotyping, haplotypes of group A type iden-HLA-B. However, a minority (z8%) of individuals lack
an inhibitory KIR (KIR3DL1) specific for Bw4 HLA-B, tically. However, heterogeneity was revealed by nu-
cleotide sequencing of KIR from donor PP, who typesconsistent with a previous population study of this re-
ceptor that used serological methods (Gumperz et al., only for group A haplotypes and expresses closely re-
lated pairs of alleles for the four inhibitory KIR genes1996). In contrast to the relatively conserved phenotype
Figure 5. Genomic Polymorphism of KIR
Genomic DNA from 18 samples (see Table 5)
of diverse ethnic origins were digested with
HindIII and analyzed by Southern blotting us-
ing the full-length cDNA probe for KIR3DL1
(KIR-NKB1). An identical pattern was seen
when a probe for KIR2DL4 (KIR-103AS), the
most divergent member of the KIR gene fam-
ily, was used (data not shown), indicating that
all of the KIR genes hybridize with both KIR
probes. The arrow indicates the 24 kb band
that distinguishes the group B KIR haplo-
types from the group A KIR haplotypes.
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(KIR2DL1, KIR2DL3, and KIR3DL1±2). This result indi- the expression by certain, putatively homozygous, indi-
viduals of one member of a pair but not the other. In thecates that the four kinds of inhibitory KIR are encoded
by separate genes. Of the other two kinds of KIR that panels we analyzed this prediction is met for KIR3DL1
and KIR3DS1, suggesting they could be alleles of thecharacterize the group A haplotypes, two alleles for
KIR2DL4 are expressed by PP and KIR2DS4 is repre- same locus.
For the pair KIR2DL1/KIR2DS1, the segregation ap-sented by a single nucleotide sequence. Thus, these
two KIR must also be encoded by separate genes. In pears to be different: individuals either have both of the
KIR or have just KIR2DL1. No individual in the panel hastotal, the evidence supports a model in which the group
A haplotypes consist of six KIR genes. KIR2DS1 without also having KIR2DL1. This pattern is
consistent with encoding of KIR2DS1 and KIR2DL1 byAll six KIR genes that characterize group A haplotypes
are also found in group B haplotypes, but individual different genes. It may also be consistent with encoding
of the two KIR by alleles, providing that a role for selec-group B haplotypes can lack certain of these genes. For
example, whereas KIR2DS4 is common to all group A tion is allowed. The rule governing receptor expression
by NKcells is that every cell carriesan inhibitory receptorhaplotypes, it is present on only a subset of group B
haplotypes. Several lines of evidence suggest that there that binds an autologous HLA class I allotype; in con-
trast, expression of noninhibitory receptors appears notare additional KIR genes present on the group B haplo-
types that are not present on the group A haplotypes. to be under similar constraint (Valiante et al., 1997b). A
possible effect of this requirement could be selection forIndirect evidence comes from Southern blots revealing
the 24 kb HindIII fragment, which is characteristic of individuals who have the allele encoding the inhibitory
receptor KIR2DL1 and against individuals who are ho-group B haplotypes and indicative of an expansion of
the KIR gene family. More direct evidence comes from mozygous for the noninhibitory receptor KIR2DS1, who
would then be much rarer than predicted by the squareconsideration of the closely related KIR2DL2, KIR2DL3,
and KIR2DS2, which are expressed simultaneously by of the allele frequency. Resolution of these alternative
explanations should come from pedigree studies andcertain individuals. KIR2DL3 is characteristic of group
A haplotypes, whereas KIR2DL2 and KIR2DS2 are char- genomic analysis of individuals who are homozygous
by consanguinity for KIR haplotypes.acteristic of group B haplotypes. This indicates that
KIR2DL2 and KIR2DS2 derive from two different genes Our results support a model in which the group A KIR
haplotypes consist of six genes: four encoding inhibitorythat arepresent on some group B haplotypes and proba-
bly related by gene duplication or gene deletion to the receptors, one encoding a noninhibitory receptor, and
one encoding a divergent receptor of uncertain cate-single KIR2DL3 gene on the group A haplotypes. A third
piece of evidence is that the noninhibitory KIR2DS3, gory. Within the population sampled, 40% of the individ-
uals carry two group A haplotypes, showing that thesewhich is found on some group B haplotypes, is relatively
divergent (DoÈ hring et al., 1996b; Valiante et al., 1997a) six genes are sufficient to provide an adequate set of
KIR for regulation of NK cells in the human immuneand may represent a distinct locus rather than an allele
of one of the other genes. KIR2DS5, which was not system. The group B KIR haplotypes are more variable
in their organization, containing one additional gene,detected in the panel we analyzed, could be a rarer
allele of the same gene as KIR2DS3. and possibly more, that encode noninhibitory receptors.
The functions of these additional genes have yet to beAlthough genomic analyses of two KIR genes and a
preliminary map of the KIR complex have been reported established, but the relatively even frequency of group
A and B haplotypes suggests that both kinds of haplo-(Selvakumar et al., 1997; Wagtmann et al., 1997; Wilson
et al., 1997), the number and organization of the KIR type are actively maintained in the population.
In a previous population study we used a monoclonalgenes on human chromosome 19 have yet to be defined.
The number of KIR genes also cannot be predicted by antibody (MAb) to examine the cell surface expression
of the HLA-Bw4±specific KIR-NKB1 (now designatedcomparison of KIR cDNA sequences, because the cDNA
sequences cannot be confidently sorted into groups KIR3DL1) by NK cells of individuals with different HLA
class I types (Gumperz et al., 1996). Although variationscorresponding to the alleles of different loci. This prop-
erty of KIR sequences contrasts with those of their HLA in KIR3DL1 expression were detected, they were not
correlated with expression of the Bw4 HLA-B ligand.class I ligands, for which locus assignments can readily
be made on the basis of coding region sequences (Par- In the present study these results are confirmed and
extended to the other KIR of known HLA specificity.ham et al., 1995). Uncertainty in assigning KIR to loci
stems in part from the apparently independent evolution Expression of a KIR does not depend on expression of
the HLA class I ligand, and individuals who lack expres-of sequences encoding the extracellular and intracellu-
lar domains. Thus certain pairs of inhibitory and nonin- sion of a particular KIR do so because they lack the
gene. A considerable majority of individuals have geneshibitory KIR are very similar in the extracellular part of
the molecule but divergent in their cytoplasmic tails. for inhibitory KIR that recognize the three well-defined
HLA-B and -C ligands, and they express these receptorsKIR2DL1/KIR2DS1 and KIR3DL1/KIR3DS1 are exam-
ples of such pairs, which could represent alleles either irrespective of their HLA type. By this mechanism the
KIR genes on human chromosome 19 can segregateof the same locus or of two closely related loci. For the
case already discussed above, the triplet of related KIR independently from the HLA genes on chromosome 6
while still maintaining compatibility between receptors(KIR2DL2, KIR2DL3, and KIR2DS2) that is expressed by
some individuals proves that there are at least two loci and the KIR ligands presented by a particular HLA class
I type.involved, but for the other pairs of KIR the evidence is
not so clear. Evidence in support of allelism would be The number of KIR ligands an individual possesses
Typing for Killer Cell Inhibitory Receptors
761
used in combination with an FITC-conjugated goat anti-rabbit IgGvaries from one to three and affects the extent to which
antiserum as the secondary reagent (Caltag, Burlingame, CA).KIR are used as inhibitory receptors by their NK cells
(Valiante et al., 1997b). The CD94:NKG2-A inhibitory re-
DNA Extraction and Southern Blot Analysis
ceptor is able to compensate for such differences be- DNA for PCR typing was prepared from 1 3 107 B lymphoblastoid
cause the HLA class I type of most, if not all, individuals cell lines (BLCL) using the QIAamp Blood Kit according to the manu-
includes a ligand for CD94:NKG2-A. The broad specific- facturer's instructions (QIAGEN, Chatsworth, CA). High-molecular-
weight DNA for Southern blot analysis was prepared from 3 3 108ity of the CD94:NKG2-A receptor for HLA-A, -B, and -C
BLCL, and 10 mg of genomic DNA was digested to completion withallotypes suggests that the origin of this receptor:ligand
restriction enzymes. The resulting DNA fragments were separatedcombination predates the diversification of HLA-A, -B,
by electrophoresis through 0.6% agarose gels in 0.53 TBE buffer.
and -C from a common ancestral class I gene. In con- Hybridizations were performed as described previously (Shum et
trast, the specificity of KIR for subsets of HLA-B or -C al., 1996), using full-length cDNA probes for KIR-NKB1 (KIR3DL1),
allotypes suggests that these receptor:ligand combina- KIR-103AS (KIR2DL4), CD94, and NKG2-A.
tions arose subsequent to the divergence of the HLA-B
RNA Extraction and Reverse Transcriptionand -C genes from HLA-A (Parham, 1994; Valiante et
Total cellular RNA was prepared from 1 3 106 NK cell clones or 1 3al., 1997a). Correlating with this difference in age of the
107 PBMC using RNAzol according to the manufacturer's instruc-
two class I receptor systems, we find that the CD94 and tions (Tel-test, Friendswood, TX). First-strand cDNA was synthe-
NKG2 genes are relatively conserved from one individual sized from NK clones and PBMC-derived RNA (0.5 mg and 5 mg
to another, whereas the KIR genes exhibit considerable RNA, respectively) by RT using oligo(dT) and Moloney murine leuke-
mia virus reverse transcriptase (GIBCO±BRL, Gaithersburg, MD) atpolymorphism.
428C for 1 hr.Our results show that humans express the products
of six or more KIR genes. In addition to this diversity
NK Receptor±Specific PCR Typingof KIR within an individual's immune system, there is
PCR amplification was performed with a pair of sense and antisense
considerable diversity in the KIR type that distinguishes primers, each possessing a 39 residue matching a polymorphic posi-
individuals within the population. This polymorphism of tion on a given NK receptor gene (Table 1). The primer length was
KIR appears analogous to that seen for MHC class I and adjusted to result in an annealing temperature of the primers be-
tween 568C and 628C. This enabled amplification of all NK receptorsII genes but contrasts with the variability of B and T cell
under the same PCR conditions. Internal control sense (59-CGCantigen receptors, where diversity is played out largely
GAG AAG ATG ACC CAG ATC -39) and antisense (59-TTG CTG ATCwithin the individual. At present, the functions of only a
CAC ATC TGC TGG-39) primers, specific for a 734 bp b-actin frag-
subset of the KIR are known, but if they all contribute ment, were included in each RT-PCR at a concentration of 0.1 mM
to the regulation of the NK cell response, then the diver- for the analysis of NK clones and 0.05 mM for PBMC. Genomic
sity of KIR and HLA class I types within the human PCR was performed without internal positive controls to increase
amplification efficiency of the larger fragments. Each experimentpopulation has the potential to modify the NK cell re-
included negative control reactions containing distilled water as thesponse in ways that are highly individualized.
surrogate template. KIR typing of NK clones included as a negative
control a feeder cell culture without NK clones to monitor possible
amplification of residual KIR transcripts from the irradiated feederExperimental Procedures
cells.
The NK receptor±specific primers were used at a concentrationCells
of 0.5 mM and stored in ready-to-use PCR plates at 2208C. Amplifi-Peripheral Blood Cells
cation of cDNA was performed in 25 ml reactions in a model 9600Samples were obtained from a total of 68 donors: 52 blood donors
thermal cycler (Perkin-Elmer, Norwalk, CT) using 0.625 U AmpliTaq(Stanford Blood Center, Stanford, CA) and 16 unrelated donors of
polymerase, 2.5 ml 103 Buffer (Perkin-Elmer), and 0.2 mM dNTPsdifferent ethnic origins (Cedars-Sinai Medical Center, Los Angeles,
(Promega, Madison, WI) under the following conditions: initial dena-CA). PBMCwere isolated from whole blood by Ficoll-Hypaque gradi-
turation at 958C for 2 min; then 60 s at 628C, 45 s at 728C, and 60ent separation.
s at 948C for the first five cycles; and then 45 s at 608C, 45 s at 728C,NK Cells
and 30 s at 948C for 25±30 cycles. Genomic PCR analysis of KIRCD32CD561 NK clones were generated and maintained in culture
and NKG2 genes was performed with 100±300 ng DNA in a modelas described previously (Yssel et al., 1984; Litwin et al., 1993).
9700 thermal cycler (Perkin-Elmer) under the following conditions:Transfected Cells
initial denaturation for 5 min at 958C; then 20 s at 978C, 45 s at 628C,KIR-NKAT1±6 (KIR2DL1±3, KIR3DL1±2, and KIR2DS2) cDNA were
and 90 s at 728C for the first five cycles; and then 20 s at 958C, 45transfected into the murine BaF/3 pre-B cell line (Lanier et al., 1997).
s at 608C, and 90 s at 728Cfor 25 cycles. Amplificationproducts wereThe NKG2-A cDNA was transfected into the murine P815 mastocy-
analyzed on ethidium bromide±prestained 1.5% (RT-PCR typing) ortoma (Lazetic et al., 1996).
0.9% (genomic typing) agarose gels.
HLA Class I Typing
Nucleotide Sequencing of KIRTwo donors, NV and PP, wereHLA class I typed by cDNA cloning and
NK receptor-specific PCR products were purified using a QIAquicksequencing as described previously (Domena et al., 1993). Donor PP
PCR Purification Kit according to manufacturer's instructionstyped as A*0101/0301, B*1501/0702, and Cw*0304/0702; donor NV
(QIAGEN) and directly sequenced in both orientations using dye-typed as A*0201/0301, B*2702/0702, and Cw*0202/0702.
labeled deoxy-terminators and a 373A automated DNA sequencer
(Applied Biosystems, Foster City, CA). Full-length KIR coding se-
quences were obtained from donor PP and NV by amplificationFlow Cytometry Analysis
The MAb HP-3E4 (anti-KIR2DL1) was generously provided by M. of KIR cDNAs with primers matching sequences in the 59 and 39
untranslated regions (Valiante et al., 1997b). PCR products wereLoÂ pez-Botet (Melero et al., 1994). The DX27 (anti-KIR2DL2±3), DX9
(anti-KIR3DL1), and DX31 (anti-KIR3DL2) MAbs have been de- cloned into a pBLUESCRIPT SK1 vector and partially sequenced
with a standard T7 oligonucleotide primer. Based on the partialscribed previously (Litwin et al., 1994; Lanier et al., 1997). All anti-
KIR MAbs were detected using a fluorescein isothiocyanate (FITC)± sequences, three to four representatives of each KIR were selected
and were sequenced completely on both strandsto obtain a consen-conjugated goat anti-mouse IgG antiserum (Caltag, Burlingame,
CA). The CD94:NKG2-A±specific polyclonal rabbit antiserum was sus sequence.
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